Silencing or stimulation? siRNA delivery and the immune system
about
Role of exosomes/microvesicles in the nervous system and use in emerging therapiesMolecular characterization of an adiponectin receptor homolog in the white leg shrimp, Litopenaeus vannameiExosomes: mediators of neurodegeneration, neuroprotection and therapeuticsBunyamwera orthobunyavirus glycoprotein precursor is processed by cellular signal peptidase and signal peptide peptidaseNew trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapiesPositive selection of primate genes that promote HIV-1 replication.Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity.Non-viral nanocarriers for siRNA delivery in breast cancer.In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weightDesign and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA deliveryEfficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications.Serum-stabilized naked caspase-3 siRNA protects autotransplant kidneys in a porcine model.Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer.Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cellsOncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation.The autoinhibitory CARD2-Hel2i Interface of RIG-I governs RNA selection.Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells.Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain developmentDocosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse BrainDextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing.GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells.RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction.Exosomes, an Unmasked Culprit in Neurodegenerative Diseases.Action and reaction: the biological response to siRNA and its delivery vehicles.Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases.Novel RNA interference-based therapies for sepsis.Advances in targeted delivery of small interfering RNA using simple bioconjugates.Prediction of Immunomodulatory potential of an RNA sequence for designing non-toxic siRNAs and RNA-based vaccine adjuvants.Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment.Oligonucleotide therapeutics: chemistry, delivery and clinical progress.Delivery strategies: RNA interference in agriculture and human health.Polymers in the Delivery of siRNA for the Treatment of Virus Infections.RNA/aTNA chimeras: RNAi effects and nucleases resistance of single and double stranded RNAs.Advancement of the Emerging Field of RNA Nanotechnology.Development of streptavidin-based nanocomplex for siRNA delivery.Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy.How to Tackle the Challenge of siRNA Delivery with Sequence-Defined Oligoamino Amides.Effective inhibition of HIV-1 production by short hairpin RNAs and small interfering RNAs targeting a highly conserved site in HIV-1 Gag RNA is optimized by evaluating alternative length formats.Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy.Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics.
P2860
Q21129255-A568B861-34C1-4AE0-A38B-8786003FCD33Q26314465-CF9FA806-37D6-44D8-8193-9A546D1E21A4Q27026606-E72B26BC-53B0-4506-BD29-90EB3B344AC3Q27468937-834B3188-5F1E-4804-932A-40002E19FCA5Q28067499-09585E50-9F0C-4DD1-8442-86C5C20F9BA2Q33637979-413D0CA0-63C4-4DE0-ABA4-12A02B05D883Q33954008-D5EE2EDB-6FB6-4D1D-903B-0833D60E7C48Q34079608-EE9B10DE-41F1-41E0-AE81-B210CFD6FC12Q34393539-08A23FB8-845A-490A-AEC5-2C66472DC351Q34782034-1440AF00-E228-4D8D-9D6C-FD6EAA98A984Q35230177-CA7B35BB-82DE-4C4E-85A5-805351439D9FQ35596539-9B000AD3-53B6-4AAB-8361-2C9795CCB3ADQ35674830-9C103FA5-F8F3-4FB2-A1AF-0C579A190FC8Q36130906-03FEA3FC-01EC-41E3-A1DE-1BB05422095CQ36296474-FD472488-8FBB-40F6-8346-010F81E52B3EQ36532655-FDEE00F7-268B-40DB-8C9F-28CCA324132FQ37021458-E1348FE5-C742-4654-88B8-C0483D758783Q37115195-9274396C-5FCA-47C8-953F-914CD00EB8BCQ37256184-73079A12-CCBD-4225-B33D-922235FE8585Q37354206-7C3B1307-FFBD-471F-AB7B-74B0ECBE717FQ37435171-2AE4D70F-8A71-4F81-B130-CB16B036B640Q37445494-F6A4ED9A-9604-4F0A-A320-B3605578AC5FQ37614565-C7AC963C-BBCA-4EEF-82F2-1317CB035E6DQ37976576-AA71C159-01EF-40C0-B51E-92CA6325E78BQ38136096-2D28A9E5-EB63-4B56-BBD6-023D66ECA546Q38176441-B6E69022-8266-4BD4-9B9D-5A8F82D6360EQ38199518-9B4264EF-A783-4031-B545-9188932EB73DQ38333686-5C828339-2C29-4E55-B695-F2EDC81A906BQ38473948-218B970D-E7F6-43F3-ADE1-64D9CDA5449FQ38618638-BA93F9FB-F2D4-4BBD-9303-C004A7AFDC06Q38851942-47D7C7ED-6EE1-4097-B9F2-CF234D00421DQ38889573-F10DA86D-D9F3-4CD9-806D-A31F65F6B4EBQ38942269-C389F959-C4FF-4C6E-8527-589B9C1E799CQ39065708-6A7C57CB-7D0B-4BBF-A5B1-C62EA6FDF92BQ39070514-2DF4B949-38CD-40B2-8750-95076A47BC90Q40523184-92585A4D-670C-45DB-B5BA-5C519002AB7DQ40689442-40D9C43F-1164-4295-AF41-D1B7E7C445B3Q41159509-01A0FCA7-5318-4385-A38E-F21C94E07884Q42124938-5F33451C-DE1E-47A8-9E4B-E960CB8BE5E6Q42318134-9EB49A7B-08D3-4D62-BC21-CB079C109206
P2860
Silencing or stimulation? siRNA delivery and the immune system
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Silencing or stimulation? siRNA delivery and the immune system
@ast
Silencing or stimulation? siRNA delivery and the immune system
@en
Silencing or stimulation? siRNA delivery and the immune system
@nl
type
label
Silencing or stimulation? siRNA delivery and the immune system
@ast
Silencing or stimulation? siRNA delivery and the immune system
@en
Silencing or stimulation? siRNA delivery and the immune system
@nl
prefLabel
Silencing or stimulation? siRNA delivery and the immune system
@ast
Silencing or stimulation? siRNA delivery and the immune system
@en
Silencing or stimulation? siRNA delivery and the immune system
@nl
P2093
P3181
P1476
Silencing or stimulation? siRNA delivery and the immune system
@en
P2093
Daniel G Anderson
James E Dahlman
Kathryn A Whitehead
Robert S Langer
P3181
P356
10.1146/ANNUREV-CHEMBIOENG-061010-114133
P407
P577
2011-01-01T00:00:00Z